Actively Recruiting
Prealbumin and IGF-1 Levels in Pediatric Chronic Cholestasis With Severe Malnutrition After Nutrition Therapy
Led by Indonesia University · Updated on 2026-05-06
15
Participants Needed
1
Research Sites
12 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if a high-energy liquid diet improves the nutritional status of children with chronic cholestasis (a liver condition that blocks bile flow). Researchers want to see if this diet helps children who are malnourished. The main questions the study aims to answer are: * Does the liquid diet raise the level of prealbumin (a marker of nutrition) in the blood? * Does the liquid diet raise the level of Insulin-like Growth Factor-1 (IGF-1) (a hormone that helps growth) in the blood? Participants will: * Consume a high-energy liquid diet for 14 days. * Give blood samples at the start and at the end of the 2-week study. * Keep a daily record of what they eat and drink in a food diary. Researchers will compare the blood test results from the start and the end of the study to see if the liquid diet works to improve the children's prealbumin and IGF-1 levels. This study is important to help children with liver problems grow better and stay healthy.
CONDITIONS
Official Title
Prealbumin and IGF-1 Levels in Pediatric Chronic Cholestasis With Severe Malnutrition After Nutrition Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children under 5 years old
- Diagnosed with chronic cholestasis and severe malnutrition
- Parental or guardian informed consent
- Willingness to use a nasogastric tube if needed
- Covered by national health insurance or other insurance
You will not qualify if you...
- Presence of comorbidities such as heart failure, chronic kidney disease, or HIV
- Severe acute infections including acute gastroenteritis, dengue fever, or pneumonia
- History of liver transplant
- History of Kasai portoenterostomy with jaundice-free status
- Currently exclusively breastfeeding
- Use of steroids or NSAIDs within two weeks before the study
- Receiving transfusion of whole blood, fresh frozen plasma, or platelets within one week before the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine, University of Indonesia, Jakarta, DKI Jakarta 10430
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
Actively Recruiting
Research Team
T
Tri Faranita, dr, Sp.A
CONTACT
K
Klara Yuliarti, Dr. dr, Sp.A(K)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here